África do Sul - inglês - South African Health Products Regulatory Authority (SAHPRA)

novartis south africa (pty) ltd - capsules - see ingredients - each capsule contains nilotinib 200,0 mg

África do Sul - inglês - South African Health Products Regulatory Authority (SAHPRA)

novartis south africa (pty) ltd - capsules - see ingredients - each capsule contains nilotinib 150,0 mg

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - nilotinib hydrochloride monohydrate; nilotinib -

Malásia - inglês - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

novartis corporation (malaysia) sdn. bhd. - nilotinib hydrochloride monohydrate -

Malásia - inglês - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

novartis corporation (malaysia) sdn. bhd. - nilotinib hydrochloride monohydrate -

Malásia - inglês - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

novartis corporation (malaysia) sdn. bhd. - nilotinib hydrochloride monohydrate -

Reino Unido - inglês - MHRA (Medicines & Healthcare Products Regulatory Agency)

novartis pharmaceuticals uk ltd - nilotinib hydrochloride monohydrate - capsule - 200mg

Reino Unido - inglês - MHRA (Medicines & Healthcare Products Regulatory Agency)

novartis pharmaceuticals uk ltd - nilotinib hydrochloride monohydrate - capsule - 150mg

Canadá - inglês - Health Canada

novartis pharmaceuticals canada inc - nilotinib (nilotinib hydrochloride monohydrate) - capsule - 200mg - nilotinib (nilotinib hydrochloride monohydrate) 200mg - antineoplastic agents

Canadá - inglês - Health Canada

novartis pharmaceuticals canada inc - nilotinib (nilotinib hydrochloride monohydrate) - capsule - 150mg - nilotinib (nilotinib hydrochloride monohydrate) 150mg - antineoplastic agents